Due to the limited data on the association between PCT levels and neuroendocrine carcinoma, an appropriate cutoff value for PCT and its corresponding sensitivity and specificity as a tumor diagnostic biomarker need to be further explored in the future. The gene discussed is CALCA; the disease is neoplasm.